Filing Impact
Filing Sentiment
Form Type
144
Metagenomi Therapeutics, Inc
Jan 12, 2026
[8-K] Metagenomi, Inc. Reports Material Event
Nov 12, 2025
[10-Q] Metagenomi, Inc. Quarterly Earnings Report
Nov 12, 2025
[8-K] Metagenomi, Inc. Reports Material Event
Sep 11, 2025
[144] Metagenomi, Inc. SEC Filing
57.45M
26.84M
Biotechnology
Biological Products, (no Diagnostic Substances)
United States
EMERYVILLE